Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 3 Withdrawn 1 Terminated 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 11 Triple Negative Breast Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Multiple Myeloma 2 Meningeal Neoplasms 2 Lymphoma, Non-Hodgkin 2 HER2-positive Breast Cancer 2 Stomach Neoplasms 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Meningeal Carcinomatosis 1 Hemangiosarcoma 1 Colorectal Neoplasms 1 Brain Neoplasms 1 Adenocarcinoma 1

Interventions

Bevacizumab 76 Fluorouracil 56 Cetuximab 47 Leucovorin 44 Oxaliplatin 43 pembrolizumab 35 Irinotecan 34 Folfox protocol 24 Capecitabine 24 HMPL-013 22 Specimen Handling 18 trifluridine tipiracil drug combination 16 Nivolumab 15 Blood Specimen Collection 15 Panitumumab 14 regorafenib 13 Magnetic Resonance Spectroscopy 13 Trifluridine 12 Standard of Care 12 Gemcitabine 12 Biopsy 12 Cisplatin 11 sintilimab 10 Interviews as Topic 10 IFL protocol 10 Drug Therapy 10 Carboplatin 9 tislelizumab 8 Trastuzumab 8 Cyclophosphamide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Colorectal Neoplasms × tucatinib × Clear all

NCT05253651 2026-06-04

MOUNTAINEER-03

Seagen Inc.

Phase 3 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡